版本:
中国

BRIEF-Intersect ENT says U.S. FDA has accepted NDA for its investigational Sinuva steroid releasing sinus implant

May 22 Intersect Ent Inc

* Intersect ENT Inc says U.S. FDA has accepted new drug application for company's investigational Sinuva™ steroid releasing sinus implant

* Intersect ENT Inc says U.S. FDA set a PDUFA target action date of January 7, 2018 Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐